B.C. expands biosimilar drug program to include treatments for Crohn's, colitis The British Columbia government says it is expanding its substitute drug program to include 1,700 patients with diseases such as Crohn's and colitis. September 06, 2019 Labels: CBC | Health News health Share to: Twitter Facebook URL Print Email
Post a Comment